Swift Biosciences Releases Targeted S Gene Panel to Accelerate Surveillance of Emerging Strains of Sars-Cov-2

Swift Biosciences of Ann Arbor, MI has released a targeted gene panel that covers 100% of the SARS-CoV-2 S gene, even with limited viral titers. The Swift Normalase® Amplicon SARS-CoV-2 S Gene Panel (SNAP) eliminates the need to perform qPCR for library normalization.